Contact
Please use this form to send email to PR contact of this press release:
UbiVac CEO Presents Pioneering Dark-Matter Cancer Vaccine Advances at Parker Institute for Cancer Immunotherapy Workshop
TO:
Bernard A Fox, PhD
UbiVac
+1 971-413-7139